Acute megakaryoblastic leukemia laboratory findings: Difference between revisions
Jump to navigation
Jump to search
(Created page with "__NOTOC__ {{Acute megakaryoblastic leukemia}} Please help WikiDoc by adding content here. It's easy! Click here to learn about editing. ==Referenc...") |
No edit summary |
||
| Line 2: | Line 2: | ||
{{Acute megakaryoblastic leukemia}} | {{Acute megakaryoblastic leukemia}} | ||
The diagnosis of AMKL (M7) is based on the following: | |||
# Bone marrow biopsy demonstrate 30% or more leukemic cells | |||
# Conducting tests that detect platelet-specific antibodies. | |||
==References== | ==References== | ||
{{reflist|2}} | {{reflist|2}} | ||
Revision as of 18:53, 3 April 2021
|
Acute megakaryoblastic leukemia Microchapters |
|
Differentiating Acute megakaryoblastic leukemia from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Acute megakaryoblastic leukemia laboratory findings On the Web |
|
American Roentgen Ray Society Images of Acute megakaryoblastic leukemia laboratory findings |
|
Acute megakaryoblastic leukemia laboratory findings in the news |
|
Blogs on Acute megakaryoblastic leukemia laboratory findings |
|
Directions to Hospitals Treating Acute megakaryoblastic leukemia |
|
Risk calculators and risk factors for Acute megakaryoblastic leukemia laboratory findings |
The diagnosis of AMKL (M7) is based on the following:
- Bone marrow biopsy demonstrate 30% or more leukemic cells
- Conducting tests that detect platelet-specific antibodies.